YUROXAN
MediGene AG
Application Filed: 2010-02-23
Trademark Application Details
CANCELLED - SECTION 8
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77942356 |
| Registration Number | 4040189 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | Adrienne L. White |
| Attorney Name | Adrienne L. White |
| Attorney Docket Number | 000337-018 |
| Law Office Assigned | L20 |
| Employee Name | CHOSID, ROBIN S |
Timeline
| 2010-02-23 | Application Filed |
| 2011-08-02 | Published for Opposition |
| 2011-10-18 | Location: PUBLICATION AND ISSUE SECTION |
| 2011-10-18 | Trademark Registered |
| 2018-05-25 | Cancelled |
| 2018-05-25 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  MediGene AG |
| Entity Statement | aktiengesellschaft |
| Address | Lochhamer Strasse 11 D-82152 Planegg/Martinsrie DE |
| Legal Entity Type | |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical and veterinary preparations for humans and animals, namely, medicines, vaccines, and serums for diagnostics, testing, prevention, treatment, and therapeutics, in particular medicines for treating cardiovascular illnesses, in particular hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for the treatment of immunological diseases, in particular autoimmune diseases in particular rheumatic disorders, polychondritis, Bechterew's disease, fibromyalgia and lupus erythematodes, rheumatoid arthritis, polyarthritis, Crohn's disease, and multiple sclerosis; medicines for treating skin diseases, in particular acne, actinic keratosis, alopecia, atopic dermatitis, Bowen's disease, cutaneous atopy, cutaneous T-cell lymphoma, Darrier's disease, Dartroud diathesis, dermatitis, eczema, genital herpes, genital warts, herpes, hyperkeratosis, hyperpigmentation, hyperplasia of the epidermis, hypopigmentation, ichthyosis, increased proliferation of skin cells, keloids, lentigo, lichen planus, melasma, molluscum contagiosum, mycosis fungoides, neoplasias, neurodermitis, pigmentation disorders, porokeratosis of Mibelli, psoriasis, removal of tattoos, rosacea, seborrhea, seborrheic keratosis, shingles, skin diseases related to inflammatory processes of skin cells, skin ulcers, vitiligo, warts, xerosis; medicines for treating tumourous diseases, in particular Astrocytomas, basal cell carcinomas, biliary cancers, bladder cancers, bone cancers, brain cancers, breast cancers, carcinomas, cervical cancers, cervical intraepithelial neoplasias, colorectal cancers, endocrine system cancers, ependymomas, epidermoid carcinomas, fibrosarcomas, gastric cancers, gastrointestinal cancers, glioblastomas, gynecologic cancers, head and neck cancers, hemangiomas, hepatomas, Hodgkin's lymphomas, Leukemia, liver cancers, lung cancers, lymphomas, medulloblastomas, meningiomas, mesothelaiomas, metastases, myelomas, neoplasias, neurectodermal cancers, neuroblastomas, neurofibromas, neurofibrosarcomas, neuronal cancers, non-Hodgkin's lymphomas, oligodendrogliomas, ovarian carcinoma, pancreatic cancers, pediatric cancers, penile cancer, pituitary adenomas, pleural cancers, renal cancer, sarcomas, Schwannomas, skin cancers, sqamous cell carcinomas, testicular cancers, thyroid cancers, thyroid tumors, urinary tract cancers, carcinoma of the prostate, melanoma, Kaposi's sarcoma, hepatocellular carcinoma; ALL OF THE ABOVE CONSISTING OF low-molecular active substances, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, T-cell proteins, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-type particles and plant extracts |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2010-02-26 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2010-03-01 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2010-05-27 | 3 DOCK D:Assigned to Examiner |
| PRIORITY ACTION WRITTEN | 2010-05-29 | 4 CPRA R:Renewal |
| PRIORITY ACTION E-MAILED | 2010-05-29 | 5 GPRA F:First Action |
| NOTIFICATION OF PRIORITY ACTION E-MAILED | 2010-05-29 | 6 GPRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2010-11-29 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2010-11-29 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2010-11-29 | 9 TEME I:Incoming Correspondence |
| PRIORITY ACTION WRITTEN | 2011-01-03 | 10 CPRA R:Renewal |
| PRIORITY ACTION E-MAILED | 2011-01-03 | 11 GPRA O:Outgoing Correspondence |
| NOTIFICATION OF PRIORITY ACTION E-MAILED | 2011-01-03 | 12 GPRN O:Outgoing Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2011-06-22 | 13 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2011-06-22 | 14 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2011-06-22 | 15 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2011-06-22 | 16 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2011-06-22 | 17 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2011-06-24 | 18 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2011-06-28 | 19 PREV O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2011-08-02 | 20 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2011-08-02 | 21 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2011-10-18 | 22 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2016-10-18 | 23 REM1 E:E-Mail |
| CANCELLED SEC. 8 (6-YR) | 2018-05-25 | 24 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 YUROXAN 78264418 2917240 Dead/Cancelled |
MediGene AG 2003-06-19 |
 YUROXAN 77942356 4040189 Dead/Cancelled |
MediGene AG 2010-02-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 